|6 Months Ended|
Jun. 30, 2019
|Share-based Payment Arrangement [Abstract]|
Restricted Stock Awards. The number of shares and weighted average grant price of restricted stock awards during the six months ended June 30, 2019 were as follows:
The total fair value of shares vested during the six months ended June 30, 2019 and 2018, determined using the closing price on the grant date, was $2.7 million and $2.8 million, respectively.
Stock Options. The Company did not grant any stock options during the six months ended June 30, 2019.
Employee Stock Purchase Plan (“ESPP”). During the six months ended June 30, 2019, the Company issued 60,258 shares under the ESPP. As of June 30, 2019, 162,120 shares remain available for issuance under the ESPP.
Total share-based compensation expense, which includes stock options, restricted stock and the ESPP, was $1.8 million and $1.5 million for the six months ended June 30, 2019 and 2018, respectively.
The entire disclosure for share-based payment arrangement.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef